Very promising news indeed. Only personal concern is that while I trust they can follow deadlines, it still forces me to put off other potent treatments such as OM, RU or nuclear cycles. It would just be silly to hit the kitchen sink with something safe like KX just around the corner, but not sure how long this lousy NW2 has on Finas alone. This, along with their protac better be worth the wait cause it's the last hype train I'm boarding, and it's got till next year to take off.
I'm sure when phase II results get released, group buys will start to pop-up way before phase III even concludes, so theoretically we may not have to wait until next year to get our hands on it. That is if the results are good of course.